战场院前疼痛控制中使用氯胺酮:一项系统评价
该系统评价检索MEDLINE 2000–2019年关于战斗院前(受伤现场或后送途中)使用氯胺酮的研究,遵循PRISMA指南并在PROSPERO注册(CRD42019115728),排除民用报告和缺乏系统数据收集的病例系列。共纳入8项研究、2029名接受氯胺酮的伤员,除一项外均为阿富汗和伊拉克冲突的美国报告,研究类型为回顾性队列或前瞻性观察分析。氯胺酮使用率从2012年纳入战术战伤救治指南前的3.9%上升至其后的19.8%;在一项研究中它是最常用的镇痛药(高达52%的伤员)。中位静脉总剂量为50 mg,疼痛强度从中度或重度降至轻度或无,有时仅需一剂;一项研究中战术后送期间给予氯胺酮与吗啡相比与收缩压升高相关。主要不良事件为言语不连贯、肢体活动和幻觉。
要点
- 纳入8项研究、2029名接受氯胺酮的伤员,除一项外均为阿富汗和伊拉克冲突的美国报告,研究类型为回顾性队列或前瞻性观察分析。
- 氯胺酮使用率从2012年纳入战术战伤救治指南前的3.9%上升至其后的19.8%。
- 在一项研究中氯胺酮是最常用的镇痛药,高达52%的伤员使用。
- 中位静脉总剂量为50 mg,疼痛强度从中度或重度降至轻度或无,有时仅需一剂。
- 主要不良事件为言语不连贯、肢体活动和幻觉;一项研究中战术后送期间氯胺酮与吗啡相比与收缩压升高相关。
适用人群与场景
- 军事创伤伤员,在战斗院前环境(受伤现场或后送途中)接受氯胺酮镇痛。
处置流程与药物剂量
- 氯胺酮静脉给药,中位总剂量为50 mg,用于战斗院前镇痛。
研究设计与关键结果
- 系统评价纳入8项研究、2029名接受氯胺酮的伤员,除一项外均为阿富汗和伊拉克冲突的美国报告,研究类型为回顾性队列或前瞻性观察分析。
- 氯胺酮使用率从2012年纳入战术战伤救治指南前的3.9%上升至其后的19.8%。
- 在一项研究中氯胺酮是最常用的镇痛药,高达52%的伤员使用。
- 当受伤现场未给予镇痛时,氯胺酮更可能在战术医疗后送期间给予。
- 中位静脉总剂量为50 mg,疼痛强度从中度或重度降至轻度或无,有时仅需一剂。
- 在一项研究中,战术后送期间给予氯胺酮与吗啡相比与收缩压升高相关。
- 主要不良事件为言语不连贯、肢体活动和幻觉。
证据类型、等级与局限
- 证据类型:系统评价,证据等级Level IV。
- 局限:已发表的军事创伤中氯胺酮使用数据罕见且异质性大。
对床旁实践的改变
- 作者认为,所有研究均倾向于支持在战斗伤员院前镇痛中以50 mg至100 mg静脉给予氯胺酮的有效性和安全性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intravenous ketamine is commonly used for pain management in the civilian prehospital setting. Several studies have evaluated its effectiveness in the military setting. To date, there has been no report reviewing the published data on the use of ketamine in this context. The objective of this systematic review was to analyze the content and quality of published data on the use of ketamine for prehospital pain management in military trauma.
METHODS: The MEDLINE database was searched for studies on ketamine use in combat prehospital settings, at point of injury or during evacuation, published between 2000 and 2019. The systematic review was conducted following PRISMA guidelines, and the protocol was registered on PROSPERO (CRD42019115728). Civilian reports and case series lacking systematic data collection were excluded.
RESULTS: Eight studies were included with 2029 casualties receiving ketamine. All but one were American reports from Afghanistan and Iraq conflicts. Studies implied retrospective cohorts or prospective observational analysis. Ketamine use rose from 3.9% during the period preceding its addition to the Tactical Combat Casualty Care guidelines in 2012 to 19.8% thereafter. It was the most common analgesic administered (up to 52% of casualties) in one of the studies. Ketamine was more likely given during tactical medical evacuation when no analgesic was provided at the point of injury. The median total intravenous dose was 50 mg. Pain intensity decreased from moderate or severe to mild or none, sometimes after only one dose. In one study, ketamine administration during tactical evacuation was associated with increased systolic blood pressure as opposed to morphine. Incoherent speech, extremity movements, and hallucinations were the main adverse events reported.
CONCLUSION: Published data on ketamine use in military trauma are rare and heterogeneous. Though, all studies tend to strengthen the belief in the efficacy and safety of ketamine when given at 50-mg to 100-mg intravenous for prehospital analgesia in combat casualties.
LEVEL OF EVIDENCE: Systematic Review, Level IV.
参考来源
- de Rocquigny G, Dubecq C, Martinez T, et al. Use of ketamine for prehospital pain control on the battlefield: A systematic review. J Trauma Acute Care Surg. 2020. PMID: 31688832. doi:10.1097/TA.0000000000002522
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。